Influence of dietary supplementation of Crassocephalum crepidioides leaf on growth, immune status, caecal microbiota, and meat quality in broiler chickens

The effect of dietary supplementation of Crassocephalum crepidioides leaf powder (CCLP) in comparison with oxytetracycline and butylated hydroxyanisole (BHA) on growth, caecal microbiota, immune status, blood chemistry, carcass traits, meat quality, and oxidative stability in broiler chickens was evaluated. Two hundred and eighty 1-day-old Arbor acre chicks were randomly assigned to a basal diet containing either no additive (control, CON), 400 ppm oxytetracycline + 150 ppm BHA (ANTIBIOX), 1000 ppm CCLP (CCLP-1), or 2000 ppm CCLP (CCLP-2) for 42 days. Each dietary group had seven replicates with ten birds per replicate. Supplemented birds had higher (P < 0.05) feed efficiency, hemoglobin, and hematocrit compared with the CON birds. Diet did not affect feed intake, body weight gain, splenic interleukin-1β, interleukin-6, interleukin-10, and serum IgM. The CCLP-2 birds had lower (P < 0.05) serum total and LDL cholesterol than did birds fed other treatments. Salmonella spp. and Escherichia coli counts and serum IgG were higher in the CON birds than in the supplemented birds. The ANTIBIOX birds had lower (P < 0.05) Lactobacillus spp. count, and higher (P < 0.05) E. coli count compared with the CCLP-supplemented birds. Carcass, muscle pH, and cook loss were not affected by diet. The CON breast meat had higher drip loss and lower redness than did the breast meat of the supplemented birds. Carbonyl content and TBARS value in the thigh and breast meat of the supplemented birds were lower (P < 0.05) than those of the CON birds. These results infer that CCLP exhibited antioxidant and antimicrobial properties that were comparable to those of BHA and oxytetracycline in the diet of broiler chickens.

Acute and sub-acute toxicity assessment of aqueous leaves extract of Crassocephalum crepidioides (Asteraceae) in Wistar rats

OBJECTIVES

Several studies establish the therapeutic properties of various plants which are sometimes a source of minerals, vitamins and phytochemical compounds. However, many studies evoked potential toxic of some. In Cameroon, Crassocephalum crepidioides (C.c) is used in folk medicine to treat several diseases, but there are not much informations about its toxicity. This study evaluate its acute and sub-acute toxicity.

METHODS

Our study was undertaken to evaluate acute and sub-acute toxicity of aqueous leaves extract of C.c. The study was conducted using the OECD guidelines about oral toxicity's study. For acute toxicity, rats were administrated single oral dose of 5,000 mg/kg body weight (b.w) and monitored for death and weight impairment during seven days. In sub-acute toxicity, experimental rats received daily doses of 250,500 and 1,000 mg/kg b.w during 28 consecutive days. The toxics effects of the extract were assessed using anthropometric, haematological, biochemical parameters as well as histology of vital body's organs (liver, kidneys, lungs and spleen).

RESULTS

lethal dose 50 (LD₅₀) was find to be greater than 5,000 mg/kg b.w in rats. In sub-acute toxicity, we observed significant increase of body weight, food and water consumption with the maximums of 15.14, 24.52 and 28.86% respectively at 1,000 mg/kg b.w. There was no significant change in haematological parameters. However, we observed significant change in biochemical parameters. Furthermore, structural disorders were noticed in liver and kidneys of animals treated with C.c.

CONCLUSION

Data obtained suggesting that C.c extract could be safe in single administration, but with toxic effects in repeated treatment.

Modulation of Blood Coagulation and Hematological Parameters by Crassocephalum crepidioides Leaf Methanol Extract and Fractions in STZ-Induced Diabetes in the Rat

Diabetes affects the homeostasis of the circulatory system. Crassocephalum crepidioides Benth S. Moore (Asteraceae) is an edible plant locally used in the treatment of wounds, stomach ulcer, and skin-related conditions in Africa and some other parts of the world. This study investigated the effects of C. crepidioides leaf methanol extract and fractions on blood coagulation profile of diabetic Wistar rats. The effect of 100 mg/kg body weight of the methanol extract and partitioned fractions of C. crepidioides on blood coagulation profile of STZ-induced diabetic rats were initially evaluated, while graded concentrations (50–200 mg/kg body weight) of the aqueous and hexane fractions were further tested in diabetic rats against standard drugs aspirin (anticoagulant) and metformin (antidiabetic). Rats were allocated into groups (n = 6) and administration was done orally, once daily for 2 weeks. The methanol extract and fractions of C. crepidioides at concentrations of 50, 100, and 200 mg/kg significantly prolonged the bleeding (58–200%), clotting (65–133%), prothrombin (176–441%), and activated partial thromboplastin (209–518%) times in diabetic rats compared to the control rats (LD₅₀ ≥ 5000 mg/kg). Highest prolongation effects were recorded in the diabetic group treated with 100 mg/kg body weight of the hexane fraction. Plasma calcium concentration and platelet counts of C. crepidioides treated diabetic rats were significantly (P < 0.05) reduced compared to diabetic control rats, while the red blood cells (RBC), hemoglobin concentration, and packed cell volume (PCV) were significantly increased. This study showed that C. crepidioides possess anticoagulant and antianemic activities. The leaves can thus be a potential source of novel anticoagulant and nutraceutical for management of the thrombotic disorder in diabetes and other diseased states.

A Review on the Potential Use of Medicinal Plants From Asteraceae and Lamiaceae Plant Family in Cardiovascular Diseases

Cardiovascular diseases are one of the most prevalent diseases worldwide, and its rate of mortality is rising annually. In accordance with the current condition, studies on medicinal plants upon their activity on cardiovascular diseases are often being encouraged to be used in cardiovascular disease management, due to the availability of medicinal values in certain dedicated plants. This review was conducted based on two plant families, which are Asteraceae and Lamiaceae, to study on their action in cardiovascular disease relieving activities, to review the relationship between the phytochemistry of Asteraceae and Lamiaceae families and their effect on cardiovascular diseases, and to study their toxicology. The medicinal plants from these plant family groups are collected based on their effects on the mechanisms that affect the cardiovascular-related disease which are an antioxidant activity, anti-hyperlipidemic or hypocholesterolemia, vasorelaxant effect, antithrombotic action, and diuresis effect. In reference to various studies, the journals that conducted in vivo or in vitro experiments, which were used to prove the specific mechanisms, are included in this review. This is to ensure that the scientific value and the phytochemicals of the involved plants can be seen based on their activity. As a result, various plant species from both Asteraceae and Lamiaceae plant family have been identified and collected based on their study that has proven their effectiveness and uses in cardiovascular diseases. Most of the plants have an antioxidant effect, followed by anti-hyperlipidemia, vasorelaxant, antithrombotic, and diuretic effect from the most available to least available studies, respectively. These are the mechanisms that contribute to various cardiovascular diseases, such as heart attack, stroke, coronary heart disease, and hypertension. Further studies can be conducted on these plant species by identifying their ability and capability to be developed into a new drug or to be used as a medicinal plant in treating various cardiovascular diseases.

β-Cell protection and antidiabetic activities of Crassocephalum crepidioides (Asteraceae) Benth. S. Moore extract against alloxan-induced oxidative stress via regulation of apoptosis and reactive oxygen species (ROS)

Background

Medicinal plants are becoming more popular in the treatment of various diseases because of the adverse effects of the current therapy, especially antioxidant plant components such as phenols and flavonoids have a protective role against oxidative stress-induced degenerative diseases like diabetes. Thus, the purpose of this study was to investigate β-cell protection and antidiabetic activities of Crassocephalum crepidioides (Asteraceae) Benth. S. Moore.

Method

The in-vitro study was conducted by the pancreatic β-cell culture and α-amylase inhibition technique which includes two methods, namely starch-iodine method and 3,5-dinitrosalicylic acid (DNSA) method. On the other hand, the in-vivo study was performed by oral glucose tolerance test (OGTT) method and alloxan-induced diabetes method by using Wistar albino rat. At the end pancreatic specimens were removed and processed for histopathological study.

Result

The plant extract showed significant (*p < 0.05, **p < 0.01) effect on hyperglycemia as compared to standard (Gliclazide) in OGTT. The plant extract showed efficient protection activity of pancreatic β-cell from cell death in INS-1 cell line by significantly reduced (*p < 0.05, **p < 0.01) the levels alloxan-induced apoptosis and intracellular reactive oxygen species (ROS) accumulation. In addition, the plant extract showed a significant (*p < 0.05, **p < 0.01) effect on hyperglycemia by increases in percent of β-cells present in each islet (45% – 60%) compared to the diabetic group.

Conclusion

The result showed that C. crepidioides had β-cell protection and antidiabetic activities in pancreatic β-cell culture and Wistar albino rat.

Electronic supplementary material

The online version of this article (doi:10.1186/s12906-017-1697-0) contains supplementary material, which is available to authorized users.

Polyphenolic Extract of Euphorbia supina Attenuates Manganese-Induced Neurotoxicity by Enhancing Antioxidant Activity through Regulation of ER Stress and ER Stress-Mediated Apoptosis

Manganese (Mn) is an important trace element present in human body, which acts as an enzyme co-factor or activator in various metabolic reactions. While essential in trace amounts, excess levels of Mn in human brain can produce neurotoxicity, including idiopathic Parkinson’s disease (PD)-like extrapyramidal manganism symptoms. This study aimed to investigate the protective role of polyphenolic extract of Euphorbia supina (PPEES) on Mn-induced neurotoxicity and the underlying mechanism in human neuroblastoma SKNMC cells and Sprague-Dawley (SD) male rat brain. PPEES possessed significant amount of total phenolic and flavonoid contents. PPEES also showed significant antioxidant activity in 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging and reducing power capacity (RPC) assays. Our results showed that Mn treatment significantly reduced cell viability and increased lactate dehydrogenase (LDH) level, which was attenuated by PPEES pretreatment at 100 and 200 µg/mL. Additionally, PPEES pretreatment markedly attenuated Mn-induced antioxidant status alteration by resolving the ROS, MDA and GSH levels and SOD and CAT activities. PPEES pretreatment also significantly attenuated Mn-induced mitochondrial membrane potential (ΔΨm) and apoptosis. Meanwhile, PPEES pretreatment significantly reversed the Mn-induced alteration in the GRP78, GADD34, XBP-1, CHOP, Bcl-2, Bax and caspase-3 activities. Furthermore, administration of PPEES (100 and 200 mg/kg) to Mn exposed rats showed improvement of histopathological alteration in comparison to Mn-treated rats. Moreover, administration of PPEES to Mn exposed rats showed significant reduction of 8-OHdG and Bax immunoreactivity. The results suggest that PPEES treatment reduces Mn-induced oxidative stress and neuronal cell loss in SKNMC cells and in the rat brain. Therefore, PPEES may be considered as potential treat-ment in Mn-intoxicated patients.